HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acetaminophen Under Scrutiny In California For Prop 65 Requirements

Executive Summary

California extends deadline for data from cancer bioassays, epidemiological studies and genotoxicity tests for review of acetaminophen as a Prop 65 chemical due to carcinogenic potential. Deadline extended to May 29 in response to Consumer Healthcare Products Association request.

Advertisement

Related Content

Acetaminophen Could Have Exemption ‘Qualifications’ If Added To Prop 65
Prop 65 Proposal Stirs Retailers To Request Manufacturers' Guarantees
Prop 65 Labeling Exemption Degree Of Difficulty Higher In Proposed Amendment
Prop 65 Private-Enforcement Reforms Won’t Disincentivize Bounty Hunting
In Brief
Research & Development In Brief

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS148706

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel